Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT03357185

Prospective Evaluation of Femoral Tripod Eversion Technique

Conditions: Atheromatous

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 37
Sponsor: Hôpital NOVO

Location: Hôpital NOVO Cergy-Pontoise

Summary

Endarteriectomy is considered as the first line treatment of femoral bifurcation atheromatous lesions. Eversion technique, similar to that used for carotid bifurcation, is safe and possible for the majority of the femoral tripod lesions. The major advantage of the eversion technique is the absence of prosthetic material to be performed. However, its use has been scarcely evaluated in the literature to date. This work aims at evaluating the long term safety and the efficacy of eversion femoral technique. Surgical technique was thoroughly described and participants were followed up for two years by serial clinical and doppler US examination.

Eligibility Criteria

Inclusion Criteria: * Age\>18 years * Lower limb atheromatous occlusive disease. * Stage 2 to 4 according to Rutherford's classification Exclusion Criteria: * Age\< 18 * Previous surgery or endovascular treatment of the ipsilateral limb * Non atheromatous disease * Pregnancy * Life-expectancy estimated to be less than one year

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03357185). StuddyBuddy aggregates publicly available trial information.